[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ATE107510T1 - Zusammensetzung gegen geschwüre. - Google Patents

Zusammensetzung gegen geschwüre.

Info

Publication number
ATE107510T1
ATE107510T1 AT90300897T AT90300897T ATE107510T1 AT E107510 T1 ATE107510 T1 AT E107510T1 AT 90300897 T AT90300897 T AT 90300897T AT 90300897 T AT90300897 T AT 90300897T AT E107510 T1 ATE107510 T1 AT E107510T1
Authority
AT
Austria
Prior art keywords
complex
ulcer
composition
ulcer composition
ulcers
Prior art date
Application number
AT90300897T
Other languages
English (en)
Inventor
Richard J Harwood
Luke T H Foo
Edward V Henry
Jay L Rheingold
Joseph S Sonk
Robert C Degroof
Original Assignee
Squibb & Sons Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Squibb & Sons Inc filed Critical Squibb & Sons Inc
Application granted granted Critical
Publication of ATE107510T1 publication Critical patent/ATE107510T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C265/00—Derivatives of isocyanic acid
    • C07C265/14—Derivatives of isocyanic acid containing at least two isocyanate groups bound to the same carbon skeleton

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Physiology (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT90300897T 1989-01-30 1990-01-29 Zusammensetzung gegen geschwüre. ATE107510T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/303,871 US4975281A (en) 1989-01-30 1989-01-30 Anti-ulcer composition

Publications (1)

Publication Number Publication Date
ATE107510T1 true ATE107510T1 (de) 1994-07-15

Family

ID=23174066

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90300897T ATE107510T1 (de) 1989-01-30 1990-01-29 Zusammensetzung gegen geschwüre.

Country Status (16)

Country Link
US (1) US4975281A (de)
EP (1) EP0381414B1 (de)
JP (1) JPH02270827A (de)
KR (1) KR900011464A (de)
AT (1) ATE107510T1 (de)
AU (1) AU626976B2 (de)
CA (1) CA2007334C (de)
DE (1) DE69010021T2 (de)
DK (1) DK0381414T3 (de)
ES (1) ES2055315T3 (de)
HU (1) HU203972B (de)
IE (1) IE64211B1 (de)
MY (1) MY105956A (de)
NZ (1) NZ232077A (de)
PT (1) PT92987B (de)
ZA (1) ZA90306B (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5196405A (en) * 1987-07-08 1993-03-23 Norman H. Oskman Compositions and methods of treating hemorrhoids and wounds
DE4022944A1 (de) * 1990-07-19 1992-01-23 Merck Patent Gmbh Sucralfat-kautablette
GB9025710D0 (en) * 1990-11-27 1991-01-09 Beecham Group Plc Novel treatment
US5164379A (en) * 1991-07-15 1992-11-17 Bristol-Myers Company Sucralfate/cyclodextrin complexes
DE4139883A1 (de) * 1991-11-29 1993-06-03 Michael Prof Dr Dittgen Verfahren zur herstellung bioadhaesiver arzneimittel
US5447918A (en) * 1992-07-27 1995-09-05 Mccullough; Ricky W. Gastrointestinal anti-irritant composition comprising sucralfate and methods of use
DK66493D0 (da) * 1993-06-08 1993-06-08 Ferring A S Praeparater, isaer til brug ved behandling af inflammatoriske tarmsygdomme eller til at opnaa forbedret saarheling
WO1995005165A1 (en) * 1993-08-13 1995-02-23 Bayer Corporation Hydrolyzed gelatin as a flavor enhancer in a chewable tablet
US6028190A (en) 1994-02-01 2000-02-22 The Regents Of The University Of California Probes labeled with energy transfer coupled dyes
US6166024A (en) 1995-03-30 2000-12-26 Mayo Foundation For Medical Education And Research Use of topical azathioprine and thioguanine to treat colorectal adenomas
WO1997030988A1 (fr) * 1996-02-21 1997-08-28 Toa Eiyo Ltd. Derives de cycloalcanopyridine, procede de production de ces derives, et medicament contre l'ulcere gastro-duodenal a base de ce compose
US6270807B1 (en) 1999-03-02 2001-08-07 L. Perrigo Company Taste-masked pharmaceutical composition
US6743820B2 (en) 2000-07-07 2004-06-01 University Of Toledo Methods for protection of stratified squamous epithelium against injury by noxious substances and novel agents for use therefor
US6887926B1 (en) 2001-11-16 2005-05-03 Oatey Co. Bonding compositions for chlorinated polymers and methods of using the same
DE102004042139B4 (de) * 2004-08-31 2009-06-10 Aristocon Verwaltungs- Gmbh Perorale Darreichungsformen zur Erzielung eines Retardierungseffektes nach der Arzneimitteleinnahme mit einer Mahlzeit
TWI445540B (zh) * 2007-04-20 2014-07-21 Ajinomoto Kk 抗低體溫組成物
LU91351B1 (de) * 2007-08-08 2009-02-09 Recipe Holding S A Bio-magnum chew, tablette
GR1008308B (el) 2013-05-31 2014-10-02 UNI-PHARMA ΚΛΕΩΝ ΤΣΕΤΗΣ ΦΑΡΜΑΚΕΥΤΙΚΑ ΕΡΓΑΣΤΗΡΙΑ ΑΒΕΕ με δ.τ. "UNI-PHARMA ABEE", Τοπικες φαρμακευτικες και ιατροτεχνολογικες συνθεσεις που περιεχουν συνδυασμους σουκραλφατης, υαλουρονικου οξεος, αργινινης και ενος φυσικου ενυδατικου παραγοντα

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3432489A (en) * 1965-11-05 1969-03-11 Chugai Pharmaceutical Co Ltd Disaccharide polysulfate aluminium compound and method
JPS5978116A (ja) * 1982-10-27 1984-05-04 Chugai Pharmaceut Co Ltd スクラルフェ−ト製剤
CA1218601A (en) * 1983-09-02 1987-03-03 Angel B. Casillan Sucralfate suspension
US4676984A (en) * 1985-08-14 1987-06-30 American Home Products Corp. Rehydratable antacid composition
AU594765B2 (en) * 1986-05-16 1990-03-15 Chugai Seiyaku Kabushiki Kaisha Sucralfate preparations for applications on esophagus mucosa

Also Published As

Publication number Publication date
AU626976B2 (en) 1992-08-13
MY105956A (en) 1995-02-28
IE900314L (en) 1990-07-30
PT92987B (pt) 1995-11-30
EP0381414B1 (de) 1994-06-22
DE69010021T2 (de) 1994-10-06
US4975281A (en) 1990-12-04
ZA90306B (en) 1990-10-31
CA2007334A1 (en) 1990-07-30
KR900011464A (ko) 1990-08-01
EP0381414A3 (de) 1991-08-07
NZ232077A (en) 1991-10-25
JPH02270827A (ja) 1990-11-05
DK0381414T3 (da) 1994-08-22
DE69010021D1 (de) 1994-07-28
HU203972B (en) 1991-11-28
AU4859290A (en) 1990-08-02
ES2055315T3 (es) 1994-08-16
HU9000379D0 (en) 1990-03-28
EP0381414A2 (de) 1990-08-08
IE64211B1 (en) 1995-07-26
CA2007334C (en) 1999-08-31
HUT53812A (en) 1990-12-28
PT92987A (pt) 1990-07-31

Similar Documents

Publication Publication Date Title
ATE107510T1 (de) Zusammensetzung gegen geschwüre.
DE69032982D1 (de) Zusammensetzungen und Verfahren zur Herstellung von im Mund zersetzlichen Heilmitteln
MX163856B (es) Composicion dentifrica oral
DE3874250D1 (de) Anaesthesiemittel enthaltende kaugummi-zusammensetzungen.
FI863708A (fi) Oraalinen hammaskiven muodostumista ehkäisevä koostumus
ATE79020T1 (de) Zahnpflegemittel.
CY2575B1 (en) Improved denture adhesive composition
FI891286A (fi) Hammaskiveä ehkäisevä oraalinen koostumus
IT8620902A0 (it) Composizioni contenenti acido usnico o suoi derivati atte all'impiego nel trattamento della carie dentaria.
DE69011813D1 (de) Kaugummizusammensetzung und ihre Herstellung.
IL78061A (en) Pharmaceutical compositions based on simethicone and guar gum for protection of the oesogastroduodenal mucous membrane
BR8601154A (pt) Composicao oral,processo de inibir a formacao de calculo dental e processo de preparar a referida composicao
KR890700315A (ko) 씹는 껌의 가공성과 조직을 최적화하는 방법 및 이로부터 만들어진 조성물
BR8802860A (pt) Composicao oral antiplaca
PT86539A (en) Pharmaceutical composition for the prophylaxis and therapy of gastric ulcer
UA37278C2 (uk) Протикашльова фармацевтична композиція для перорального введення
CA2177961A1 (en) Use of dimeticone for treating aphthae and stomatitis
DE3667914D1 (de) Entzuendungshemmende zusammensetzungen und verfahren.
SE7810158L (sv) Infrarodstralningskommunikationssystem
IL70990A0 (en) Pharmaceutical compositions containing glyceryl mononitrates
ATE156352T1 (de) Antirauchmittel
SE9300082D0 (sv) Novel colon- or ileum-specific steroid derivatives
RU93042104A (ru) Противокашлевая композиция, содержащая декстрометорфан, способ ее применения
RU98112055A (ru) Способ лечения заболеваний слизистой оболочки рта у больных с вторичными иммунодефицитами
IT8719390A0 (it) Composizione farmaceutica per la prevenzione e il trattamento dell'aterosclerosi.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time